معرفی
Dr. Paul Bonnitcha is a Clinical Senior Lecturer at the Central and Northern Clinical Schools within the Medical Faculty of the University of Sydney. He also serves as a Chemical Pathologist at Royal North Shore and St Vincent's Hospital. His academic career spans roles in clinical lecturing, research, and medical practice, with a focus on translational research at the intersection of chemistry and medicine.
Education: BSc (Advanced) Honours, MSc from the University of Sydney, D.Phil (Oxon) from Oxford, and MBBS. His pre-medical research included developing imaging agents for hypoxia during his Oxford PhD, followed by further studies in molecular mechanisms of hypoxia targeting at Sydney's Chemistry Faculty.
Research Interests: Dr. Bonnitcha's work centers on Metabolomics, Translational Research, and Mass Spectrometry, with a focus on hypoxia's role in pathologies like atherosclerosis and cancer. He explores lipid biomarkers in cardiovascular disease and oncology, including drug resistance mechanisms in prostate cancer. His projects include validating lipid signatures for poor-prognosis cancers and developing clinically accessible biomarker tools.
Key Achievements: Over 30 publications across journals like EBioMedicine and Clinical Chemistry, plus grants from the RCPA and Sydney Medical School. Notable awards include the 2020 RCPA Quality Assurance Grant and multiple academic scholarships from Sydney and Oxford. He has pioneered methods for vitamin C analysis and plasma biomarker quantification using LC-MS/MS.
Teaching and Supervision: Leads courses in Biochemistry, Metabolomics, and Drug Design. Current projects include investigating NAFLD biomarkers and cardiovacular disease blood markers. He collaborates with teams at NSW Health Pathology and Royal North Shore Hospital.
Professional Affiliations: Fellow of the Royal College of Pathologists of Australasia, Australasian Association of Clinical Biochemists, and Royal Australian Chemistry Institute (Chartered Chemist). Active in translational research initiatives and quality assurance programs in clinical biochemistry.
